Evidence map›Paper›PMID 42121287›Full record

ArticleGenome biology2026

scArchon: a scalable benchmarking framework for assessing single-cell perturbation models.

Jean Radig, Robin Droit, Daria Doncevic, Albert Li, Duc Thien Bui, Luis Herfurth, Thaddeus Kühn, Carl Herrmann

Abstract read
In one paragraph

Article in Genome biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jean RadigInstitute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, Heidelberg, Germany. jean.radig@bioquant.uni-heidelberg.de.
Robin DroitInstitute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, Heidelberg, Germany.
Daria DoncevicInstitute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, Heidelberg, Germany.
Albert LiInstitute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, Heidelberg, Germany.
Duc Thien BuiInstitute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, Heidelberg, Germany.
Luis HerfurthInstitute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, Heidelberg, Germany.
Thaddeus KühnInstitute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, Heidelberg, Germany.
Carl HerrmannInstitute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, Heidelberg, Germany. carl.herrmann@uni-heidelberg.de.

Funding

Deutsche Forschungsgemeinschaft HE 7201/4-1
6 · The paper itself

Abstract

backgroundThe accurate prediction of cellular responses to perturbations, such as drug treatments, remains a pivotal challenge in single-cell transcriptomics. While numerous deep learning tools have been developed for this task, their systematic benchmarking across diverse datasets and performance metrics has been limited.

resultsHere, we present scArchon, a reproducible, modular benchmarking platform built on Snakemake. It is designed to evaluate perturbation response prediction tools in an unbiased and extensible manner. Employing six representative single-cell RNA-seq datasets, we compare leading methods such as scGen, CPA, trVAE, scPRAM, scVIDR, scDisInFact, SCREEN, scPreGAN, and CellOT against baselines. We assess model performance using a composite of statistical and biological metrics. Our analysis reveals heterogeneous performance. While methods like trVAE, scGen, scPRAM, and scVIDR achieve robust results across multiple datasets, other tools occasionally underperform even compared to linear or control baselines. Notably, models with favorable quantitative scores may fail to retain key biological perturbation signatures, underscoring the need for gene-level evaluation.

conclusionsscArchon provides a unified, extensible foundation for large-scale, standardized benchmarking of perturbation prediction tools, facilitating methodological transparency and accelerating development in this rapidly evolving field. We encourage adoption of scArchon and sharing of containerized tools to drive progress in single-cell perturbation modeling.

Indexed as

BenchmarkingSingle-Cell AnalysisSoftwareAnimalsHumansSingle-Cell Gene Expression Analysis

Identifiers

PMID42121287
PMCPMC13162514

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.